President and Chief Executive Officer

Warren C. Lau is Nexus BioPharma Inc.'s President and Chief Executive Officer and Director, a position he has held since the formation of the company. Previously, Mr. Lau was a biotech entrepreneur and product development visionary many times over.

He also served as Founder, President and CEO, and Chief Financial Officer of MetaStat, Inc. (MTST-OTCBB) for six years.

In 2003, Mr. Lau founded PharmaFrontiers Corp. (now Opexa Therapeutics, Inc OPXA-NASDAQ). He also served as President, Chief Executive Officer, Treasurer and Board Member. Opexa has subsequently negotiated product development deals with Novartis AG and Merck Serono.

In 1996, Mr. Lau started Adventrx Pharmaceuticals, Inc., now Mast Therapeutics, Inc. (MSTX-NYSE MKT). He served as President and CEO and as a member of its Board of Directors from July 1996 through November 2001. During his time as President and CEO, the Company completed two acquisitions - with Immune Complex Corporation (1997) and Biokeys Pharmaceuticals, Inc.

From November 1997 to September 1998, Mr. Lau served as a director of Immune Complex Corporation and Synthetic Genetics, Inc., privately held biotechnology companies.